Skip to content

Ihc

by Slmp, LLC 260 variants

Ihc (SAM-MM09-2) is a Class I device made by Slmp, LLC, listed in FDA GUDID since 7 Mar 2025 (UDI-DI 00810170552311), registry data as of 31 May 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 31 May 2026.

Regulatory status

as of registry sync 31 May 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00810170552311 UDI-DI Date7 Mar 2025ListedStatusListed GUDID: in commercial distribution

Official records

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Generic name
Bcl-2 oncoprotein IVD, antibody
Model / Ref / Catalog
(BTO) Sample Bcl2 Oncoprotein Antibody (2ml), SAM-MM09-2
Primary DI / UDI-DI
00810170552311
FDA product code
NJT
GMDN term
Bcl-2 oncoprotein IVD, antibody
Device class
Class I
Regulation number
864.1860
GUDID distribution status
In Commercial Distribution

Related devices

Category: Bcl-2 oncoprotein IVD, antibody

Other devices from Slmp, LLC

See all devices from Slmp, LLC →

Properties

  • Single use
  • Premarket exempt
Other properties (13, all answered No)